April 3, 2009
-
Division of Drug Marketing,
Advertising, and Communications
issues 14 letters
-
Drug Shortages: Current Drug
Shortage: Metoprolol succinate
extended release tablets
(updated)
-
New and Generic Drug Approvals
-
Abacavir Sulfate and
Lamivudine Tablets,
Matrix Laboratories, Ltd.,
Tentative Approval
-
Afinitor (everolimus)
Tablets, Novartis
Pharmaceuticals Corp.,
Approval
-
Budesonide Inhalation
Suspension, Apotex, Inc.,
Approval
-
Children's Cetirizine
Hydrochloride Allergy
Syrup, Dr. Reddy's
Laboratories, Ltd., Approval
-
Children's Cetirizine
Hydrochloride Hives Relief
Syrup, Dr. Reddy's
Laboratories, Ltd., Approval
-
Clinoril (sulindac)
Tablets, Merek & Co., Inc.,
Labeling Revision
-
Drospirenone and Ethinyl
Estradiol Tablets, Barr
Laboratories, Inc., Approval
-
Nevirapine Tablets,
MacLeods Pharmaceuticals,
Ltd., Tentative Approval
-
Niaspan (niacin)
Extended-Release Tablets,
Abbott Laboratories,
Labeling Revision
-
Topiramate Tablets,
InvaGen Pharmaceuticals,
Inc., Approval
-
Starting June 1 2009, FDA
will no longer accept paper
submission for Registration and
Listing. For more information,
visit the
FDA Data Standards Council
website or contact
spl@fda.hhs.gov
April 2, 2009
April 1, 2009
March 31, 2009
-
FDA Acts to Halt Marketing of
Certain Unapproved Prescription
Narcotic Drugs
-
New and Generic Drug Approvals
-
NegGram (nalidixic acid)
Tablets, Sanofi Aventis U.S.
LLC, Labeling Revision
-
Topiramate Tablets,
Mylan Pharmaceuticals Inc.,
Approval
-
Topiramate Tablets,
Cobalt Laboratories, Inc.,
Approval
-
Topiramate Tablets,
Glenmark Generics Ltd.,
Approval
-
Topiramate Tablets,
Apotex Inc., Approval
-
Topiramate Tablets,
Zydus Pharmaceuticals USA
Inc., Approval
-
Topiramate Tablets,
Roxane Laboratories, Inc.,
Approval
-
Topiramate Tablets, Barr
Laboratories, Inc., Approval
-
Topiramate Tablets,
Ranbaxy Laboratories Ltd.,
Approval
-
Topiramate Tablets,
Unichem Laboratories Ltd.,
Approval
March 30, 2009
-
New and Generic Drug Approvals
-
Axert (almotriptan
malate) Tablets,
Ortho-McNeil Pharmaceutical,
Inc., Labeling Revision
-
Crestor (rosuvastatin
calcium) Tablets, IPR
Pharmaceuticals, Inc.,
Labeling Revision
-
Dalmane (flurazepam
hydrochloride) Capsules,
Valeant Pharmaceuticals,
International, Labeling
Revision
-
Lipitor (atorvastatin
calcium) Tablets, Pfizer
Ireland Pharmaceuticals,
Labeling Revision
-
Myfortic (mycophenolic
acid) Delayed-Release
Tablets, Novartis
Pharmaceuticals Corp.,
Labeling Revision
-
Nuvigil (armodafinil)
Tablets, Cephalon, Inc.,
Formulation Revision
-
Theophylline in 5% Dextrose
Injection, Hospira, Inc.,
Labeling Revision
-
Topiramate Tablets,
Aurobindo Pharma Ltd.,
Approval
-
Topiramate Tablets, TEVA
Pharmaceuticals USA,
Approval
-
Topiramate Tablets,
Torrent Pharma Inc.,
Approval
-
Topiramate Tablets,
Cipla Ltd., Approval
CDER
Drug Links
|
Hot Topics
CBER Links
|
|
April 3, 2009 |
 |
Class I Medical
Device Recall:
Tri-State Hospital
Supply Corporation -
Multiple Trays and
Kits
 |
| |
|
April 2, 2009 |
 |
CDRH Event Problem
Codes
 |
 |
Medical Device
Safety, Tips &
Articles: Danger:
"Sandbag" in the MRI
Room
 |
 |
Medical Device
Safety, Tips &
Articles: Exertion
Can Disrupt
Axillofemoral Bypass
Grafts
 |
 |
Medical Device
Safety, Tips &
Articles: Use Infant
Heel Warmers with
Care
 |
| |
|
April 1, 2009 |
 |
Federal Register:
Medical Devices;
Technical Amendment.
 |
 |
Obstetrics and
Gynecology Devices
Panel Advisory
Meeting, December
13-14, 2007 - Final
Minutes
 |
 |
Ophthalmic Devices
Panel Advisory
Meeting, March 27,
2009 - Final Roster,
Final Questions,
Slides, Brief
Summary
 |
 |
Orthopaedic and
Rehabilitation
Devices Panel
Advisory Meeting,
March 31, 2009 -
Agenda, Roster,
Briefing, Questions,
Brief Summary
 |
 |
PMA
Final Decisions for
February 2009
 |
| |
|
March 30, 2009 |
 |
Guidance for
Industry and FDA
Staff: Regulatory
Requirements for
Hearing Aid Devices
and Personal Sound
Amplification
Products
  |
| |
|
|
This
Week
Rule Changes:
21 CFR Parts
814
-
5
CFR
Changes since April 2008 |
|
Friday,
April
03, 2009 |
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals
1529315295 [E97471]
[TEXT] [PDF]
1529515296 [E97472]
[TEXT] [PDF]
|
|
Thursday,
April 02, 2009 |
NOTICES
Draft Guidance for Industry;
Availability:
Somatic Cell Therapy for
Cardiac Disease,
14992 [E97350]
[TEXT] [PDF]
|
|
Wednesday.
April 01, 2009 |
RULES
Revision
of Organization and
Conforming Changes to
Regulations
1472014725 [E97349]
[TEXT] [PDF]
|
|
Tuesday,
March 31, 2009 |
RULES
Medical Devices:
Technical
Amendment
14478 [E97073]
[TEXT] [PDF]
|
|
Monday,
March 30, 2009 |
|
NOTICES
Agency
Information Collection
Activities; Proposals,
Submissions, and Approvals,
1413514137 [E97002]
[TEXT] [PDF]
|
|
|